Showing results (111-120 of 290) with videos related to
Sort By:
Pageof 29
Gut|May 1, 1992
Oral fluticasone propionate in active distal ulcerative colitisP Angus, J A Snook, M Reid, et al.Inflammatory Bowel Diseases|January 4, 2013
A randomized, double-blind, placebo-controlled trial of olsalazine for active Crohn's diseaseJ P Wright, D P Jewell, R Modigliani, et al.Clinical and Experimental Immunology|June 1, 1981
T lymphocyte subsets in human intestinal mucosa: the distribution and relationship to MHC-derived antigensW S Selby, G Janossy, G Goldstein, et al.Gut|August 1, 1992
Epithelial cells bearing class II molecules stimulate allogeneic human colonic intraepithelial lymphocytesP Hoang, B Crotty, H R Dalton, et al.Genes and Immunity|February 24, 2001
Is interleukin-6 important in inflammatory bowel disease?K Koss, J Satsangi, K I Welsh, et al.Gut|January 1, 1992
Salicylates used in inflammatory bowel disease and colchicine impair interferon-gamma induced HLA-DR expressionB Crotty, P Hoang, H R Dalton, et al.Clinical Science (London, England : 1979)|July 31, 1998
Genetics of inflammatory bowel diseaseJ Satsangi, M Parkes, D P Jewell, et al.Mediators of Inflammation|December 5, 1998
The effect of interleukin-10 and transforming growth factor beta-1 on HLA-DR expression in colonic epithelial cellsM J Zimmerman, G R Radford-Smith, D P JewellAlimentary Pharmacology & Therapeutics|April 19, 2007
Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006S L Jakobovits, D P Jewell, S P L TravisDigestion|January 1, 1984
Alpha 1-antitrypsin serum concentration and phenotypes in ulcerative colitisI Biemond, W S Selby, D P Jewell, et al.Pageof 29